Specialty Ophthalmology
-
Featured
Turning Back the Clock on Aged Eye Cells
A team of researchers at Mass Eye and Ear and Harvard Medical School have successfully restored vision in elderly mice by turning back the clock on their aged nerve cells in the retina to recapture their youthful function.
-
Featured
Mass Eye and Ear Doctors Collaborate with Dana-Farber to Rebuild Damaged Corneas Using Patients' Own Stem Cells for the First Time in the U.S.
Surgeons at Mass Eye and Ear are the first in the U.S. to have replaced the eye surface of patients who each experienced chemical burns to one eye—by using their own stem cells taken from the other healthy eye—in a technique known as cultivated autologous limbal epithelial cell transplantation.
-
Selpercatinib Shows Marked Antitumor Activity in RET-Altered Thyroid Cancer
Lori J. Wirth, MD, of the Center for Head and Neck Cancers, and colleagues observed marked antitumor activity with selpercatinib in patients with RET-mutant medullary thyroid cancer, as well as promising activity in a small cohort with RET fusion–positive thyroid cancers. RET mutations, which are associated with...
-
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
The Department of Ophthalmology at Massachusetts Eye and Ear/Massachusetts General Hospital leads the ophthalmology community in developing and implementing outcome measures in every subspecialty area—setting the standard for transparency, accountability, and continued quality improvement in the field.
-
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
In the first study of its kind, Lucia Sobrin, MD, MPH, and John H. Kempen, MD, MPH, PhD, MHS, of the Massachusetts Eye and Ear/Mass General Hospital Department of Ophthalmology, and colleagues found a low risk of noninfectious uveitis among women using hormonal contraceptives or menopausal hormone replacement therapy.
-
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
Milica A. Margeta, MD, PhD, and Janey L. Wiggs, MD, PhD, of the Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology have demonstrated that the APOE ε4 allele, the strongest genetic risk factor for late-onset Alzheimer's disease, has a protective effect against primary open-angle glaucoma.
Ophthalmology contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Tobias Elze, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Central Visual Field Patterns Identified by Artificial Intelligence Improve Prediction of Glaucoma Progression
-
Ula V. Jurkunas, MD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
